For seemingly the first time in history, an algae fuel blend will be sold to regular consumers in select cities in Northern California through a month-long pilot program for gas station owner Propel Fuels and algae fuel maker Solazyme. Read more »
Genomics guru Craig Venter and his startup Synthetic Genomics might be hitting some hurdles with their partnership with Exxon, but on Monday the company announced that it will create a joint venture with Mexican investing group Plenus to use genomics to create more sustainable crop production. Read more »
Biofuels made from algae that will be able to scale, and compete with oil, will have to be synthesized and will not come from nature, says genomics scientist and entrepreneur Craig Venter. That notion could put a damper on Venter’s current deal with oil giant Exxon. Read more »
Algae oil company Solazyme, which went public in May of this year, reported both revenue and losses up for the second quarter of the year. At the same time, the company said it expects to produce 500,000 metric tons of algae oil by 2015. Read more »
On its first day of trading, algae oil and fuel company Solazyme, saw its shares trade up around 15 percent from its IPO price of $18 per share. At one point Solazyme’s shares hit $22 per share, but leveled back down to close at $20.71. Read more »
This morning, as algae oil maker Solazyme made its debut on the Nasdaq, the company’s co-founders and investors are popping the champagne corks on pricing shares at the high end at $18 per share. Who made good in Solazyme’s debut? Hint: The Roda Group, co-founders and Braemar. Read more »
Algae oil and fuel maker Solazyme priced shares for its IPO late last night at $18 per share — above its previously estimated price range — enabling the company to raise around $198 million when it debuts on the Nasdaq on Friday. Read more »
Algae oil maker Solazyme has set the estimated terms of its planned IPO and boosted its maximum offering to $184 million, almost double the $100 million IPO it filed for in March. Solazyme plans to sell 9.98 million shares at a range of $15 to $17. Read more »
